Expanding the analysis to identify DNA methylation events specific for individual B-cell malignancies allowed the identification of a larger number of candidate genes, including the identification of SLC22A15 as a novel tumour suppressor gene in ALL. This evidence concerns the gene SLC22A15 and acute lymphoblastic leukemia.